company background image
BLISSGVS logo

Bliss GVS Pharma NSEI:BLISSGVS 株式レポート

最終価格

₹134.31

時価総額

₹14.3b

7D

3.4%

1Y

50.7%

更新

27 Sep, 2024

データ

会社財務

Bliss GVS Pharma Limited

NSEI:BLISSGVS 株式レポート

時価総額:₹14.3b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

BLISSGVS 株式概要

ブリスGVSファーマ社は、インド国内外において医薬製剤の開発、製造、販売を行っている。

BLISSGVS ファンダメンタル分析
スノーフレーク・スコア
評価4/6
将来の成長0/6
過去の実績4/6
財務の健全性6/6
配当金3/6

Bliss GVS Pharma Limited 競合他社

価格と性能

の歴代最高値、変動、値下がりまとめBliss GVS Pharma
過去の株価
現在の株価₹134.31
52週高値₹149.60
52週安値₹77.35
ベータ0.97
11ヶ月の変化5.14%
3ヶ月変化32.30%
1年変化50.66%
33年間の変化22.60%
5年間の変化31.94%
IPOからの変化230.41%

最新ニュース

These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Safely

Aug 25
These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Safely

Bliss GVS Pharma Limited's (NSE:BLISSGVS) Prospects Need A Boost To Lift Shares

Aug 07
Bliss GVS Pharma Limited's (NSE:BLISSGVS) Prospects Need A Boost To Lift Shares

Recent updates

These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Safely

Aug 25
These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Safely

Bliss GVS Pharma Limited's (NSE:BLISSGVS) Prospects Need A Boost To Lift Shares

Aug 07
Bliss GVS Pharma Limited's (NSE:BLISSGVS) Prospects Need A Boost To Lift Shares

Increases to Bliss GVS Pharma Limited's (NSE:BLISSGVS) CEO Compensation Might Cool off for now

Jul 19
Increases to Bliss GVS Pharma Limited's (NSE:BLISSGVS) CEO Compensation Might Cool off for now

Bliss GVS Pharma's (NSE:BLISSGVS) Dividend Will Be ₹0.50

Jul 18
Bliss GVS Pharma's (NSE:BLISSGVS) Dividend Will Be ₹0.50

Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50

Jul 04
Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50

We Think Bliss GVS Pharma's (NSE:BLISSGVS) Solid Earnings Are Understated

May 10
We Think Bliss GVS Pharma's (NSE:BLISSGVS) Solid Earnings Are Understated

Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Right But Growth Is Lacking

Apr 27
Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Right But Growth Is Lacking

Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?

Feb 20
Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?

There Is A Reason Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Undemanding

Jan 26
There Is A Reason Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Undemanding

Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?

Jul 14
Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?

Bliss GVS Pharma (NSE:BLISSGVS) Has Affirmed Its Dividend Of ₹0.50

Sep 11
Bliss GVS Pharma (NSE:BLISSGVS) Has Affirmed Its Dividend Of ₹0.50

Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50

Aug 28
Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50

These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well

May 21
These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well

Estimating The Intrinsic Value Of Bliss GVS Pharma Limited (NSE:BLISSGVS)

Apr 08
Estimating The Intrinsic Value Of Bliss GVS Pharma Limited (NSE:BLISSGVS)

A Look At Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Returns

Mar 18
A Look At Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Returns

Here's How We Evaluate Bliss GVS Pharma Limited's (NSE:BLISSGVS) Dividend

Feb 25
Here's How We Evaluate Bliss GVS Pharma Limited's (NSE:BLISSGVS) Dividend

Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet

Feb 08
Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet

What Type Of Shareholders Make Up Bliss GVS Pharma Limited's (NSE:BLISSGVS) Share Registry?

Jan 21
What Type Of Shareholders Make Up Bliss GVS Pharma Limited's (NSE:BLISSGVS) Share Registry?

Do Its Financials Have Any Role To Play In Driving Bliss GVS Pharma Limited's (NSE:BLISSGVS) Stock Up Recently?

Jan 08
Do Its Financials Have Any Role To Play In Driving Bliss GVS Pharma Limited's (NSE:BLISSGVS) Stock Up Recently?

How Is Bliss GVS Pharma's (NSE:BLISSGVS) CEO Paid Relative To Peers?

Dec 26
How Is Bliss GVS Pharma's (NSE:BLISSGVS) CEO Paid Relative To Peers?

Did Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Deserve to Gain 14%?

Dec 13
Did Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Deserve to Gain 14%?

Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?

Nov 30
Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?

Bliss GVS Pharma Limited (NSE:BLISSGVS) Insiders Increased Their Holdings

Nov 18
Bliss GVS Pharma Limited (NSE:BLISSGVS) Insiders Increased Their Holdings

Does Bliss GVS Pharma Limited (NSE:BLISSGVS) Have A Place In Your Dividend Portfolio?

Nov 06
Does Bliss GVS Pharma Limited (NSE:BLISSGVS) Have A Place In Your Dividend Portfolio?

Is Bliss GVS Pharma (NSE:BLISSGVS) A Risky Investment?

Oct 25
Is Bliss GVS Pharma (NSE:BLISSGVS) A Risky Investment?

Is Bliss GVS Pharma Limited's (NSE:BLISSGVS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Oct 07
Is Bliss GVS Pharma Limited's (NSE:BLISSGVS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

How Much Is Bliss GVS Pharma Limited (NSE:BLISSGVS) CEO Getting Paid?

Sep 19
How Much Is Bliss GVS Pharma Limited (NSE:BLISSGVS) CEO Getting Paid?

What Is The Ownership Structure Like For Bliss GVS Pharma Limited (NSE:BLISSGVS)?

Sep 04
What Is The Ownership Structure Like For Bliss GVS Pharma Limited (NSE:BLISSGVS)?

株主還元

BLISSGVSIN PharmaceuticalsIN 市場
7D3.4%1.5%2.5%
1Y50.7%62.0%46.3%

業界別リターン: BLISSGVS過去 1 年間で49.4 % の収益を上げたIndian Pharmaceuticals業界を下回りました。

リターン対市場: BLISSGVS過去 1 年間で43.9 % の収益を上げたIndian市場を上回りました。

価格変動

Is BLISSGVS's price volatile compared to industry and market?
BLISSGVS volatility
BLISSGVS Average Weekly Movement6.4%
Pharmaceuticals Industry Average Movement6.2%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.3%
10% least volatile stocks in IN Market3.9%

安定した株価: BLISSGVS過去 3 か月間に大きな価格変動はありませんでした。

時間の経過による変動: BLISSGVSの 週次ボラティリティ ( 6% ) は過去 1 年間安定しています。

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
1984831Gagan Sharmawww.blissgvs.com

Bliss GVS Pharma 社は、インド国内外において医薬製剤の開発、製造、販売を行っている。同社は、カプセル、クリーム/ゲル/軟膏、注射・経口懸濁液用乾燥粉末、発泡性錠剤、点眼薬/点耳薬、注射薬、液剤、トローチ、点鼻薬、経口固形剤、非経口剤、ペッサリー、サシェ、ソフトゼラチンカプセル、座薬、懸濁液、外用剤、経皮吸収パッチなどの医薬品を提供している。また、バーム、鼻用吸入器、一般用医薬品、石油ゼリー、ロールオン、石鹸、スプレー、膣洗浄剤などのヘルスケア製品も提供している。さらに、鎮痛剤、制酸剤、抗不安剤、血液安定剤などの治療用製品も提供している;抗菌薬、抗生物質、抗糖尿病薬、抗下痢薬、鎮吐薬、抗真菌薬、抗痔疾薬、抗蠕虫薬、抗感染症薬、抗炎症薬、抗マラリア薬、抗微生物薬、抗麦角薬、抗酸化薬、抗原虫薬、抗下痢薬、抗敗血症薬、抗痙攣薬、抗潰瘍薬、抗潰瘍薬;咳止めシロップと鼻の充血除去剤、勃起不全、喉頭炎、咽頭炎用の製品。さらに、フケ防止シャンプー、食欲増進剤、手指消毒剤、健康・栄養補助食品、殺虫剤、蚊よけ剤、保湿剤、チクチク粉、美白ローション、膣内避妊薬、膣衛生用品、ビタミン補助食品、アミノ酸製剤、鉄剤、鎮咳剤、食欲増進剤、抗アレルギー剤、ボディサプリメント、耳垢溶解剤、経口補水剤なども提供している。同社は製品を輸出している。ブリスGVSファーマ社は1984年に設立され、インドのムンバイを拠点としている。

Bliss GVS Pharma Limited 基礎のまとめ

Bliss GVS Pharma の収益と売上を時価総額と比較するとどうか。
BLISSGVS 基礎統計学
時価総額₹14.34b
収益(TTM)₹814.66m
売上高(TTM)₹7.94b

17.3x

PER(株価収益率

1.8x

P/Sレシオ

BLISSGVS は割高か?

公正価値と評価分析を参照

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
BLISSGVS 損益計算書(TTM)
収益₹7.94b
売上原価₹4.01b
売上総利益₹3.93b
その他の費用₹3.11b
収益₹814.66m

直近の収益報告

Jun 30, 2024

次回決算日

該当なし

一株当たり利益(EPS)7.76
グロス・マージン49.47%
純利益率10.26%
有利子負債/自己資本比率10.0%

BLISSGVS の長期的なパフォーマンスは?

過去の実績と比較を見る

配当金

0.4%

現在の配当利回り

7%

配当性向